Biolase stock forecast.

BIOLASE Stock Buy Hold or Sell Recommendation. BIOL Stock. USD 0.54 0.02 3.57%. Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding BIOLASE is 'Strong Sell'. Macroaxis provides BIOLASE buy-hold-or-sell recommendation only in the context of selected investment horizon and …BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants PR Newswire - Wed Sep 13, 10:16PM CDT. /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten...The BIOLASE stock prediction results are shown below and presented as a graph, table and text information. BIOLASE stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for BIOLASE analysts is $ 21.38. Today 200 Day Moving Average is the resistance level (15.93 $).View the latest Biolase Inc. (BIOL) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Shortly following the special meeting, the Board of Directors exercised such discretion to effect a 1-for-100 reverse stock split that will become effective at 11:59 p.m. Eastern Time on July 27, 2023, and the Company's common stock will begin trading on a split-adjusted basis at the opening of the market on July 28, 2023.

When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.

Biolase stock price target cut to $11 from $14 at Ascendiant Capital Mar. 29, 2023 at 6:10 a.m. ET by Tomi Kilgore Biolase started at speculative buy with $2 stock price target at …US0909117022. BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to ... Nov 13, 2023 · BIOLASE, Inc. Provides Revenue Forecast for the Third Quarter Ending September 30, 2022 and Full Year of 2022 Aug 12 BIOLASE, Inc. to Report Q2, 2022 Results on Aug 11, 2022 Based on 3 Wall Street analysts offering 12 month price targets for Biolase in the last 3 months. The average price target is €0.25 with a high forecast of €0.36 and a low forecast of €0.09. The average price target represents a

In late afternoon trading, the technology-focused benchmark was up 1.3% to 13,823, its best level since April 2022, boosted by strong performances from Nvidia and Alphabet during the session. With ...

BIOLASE stock has a strong buy rating from 3 analysts, who predict an increase of 6,566.47% to $113.33 in the next 12 months. The average price target is …

Examining BIOLASE Inc.'s Potential Stock Forecast in Dental Technology Market BIOLASE Inc. (BIOL) is a medical device company focusing on the development, manufacture, and marketing of dental lasers. They have developed some of the best technology in the field, including the Waterlase system, which uses water technology to cut teeth with ... With the interplay of data, predictions, and real-time performance, BIOLASE's stock emerges not just as an investment opportunity but as a narrative unfolding in the grand theatre of the financial markets. Each high, low, surge, and dip is a chapter, and every investor, a reader and co-author of this evolving tale.Biolase, Inc. (BIOL) stock forecast and price target. Find the latest Biolase, Inc. BIOL analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.The Short Squeeze Score is the result of a sophisticated, multi-factor quantitative model that identifies companies that have the highest risk of experiencing a short squeeze. The scoring model uses a combination of short interest, float, short borrow fee rates, and other metrics. The number ranges from 0 to 100, with higher numbers indicating ...Biolase announces reverse stock split SA News Fri, Apr. 29, 2022. Biolase GAAP EPS of -$0.03, revenue of $12.4M ... provides forecast SA News Thu, May 13, 2021 1 Comment. Biolase EPS misses by $0. ...It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...The BIOLASE stock prediction results are shown below and presented as a graph, table and text information. BIOLASE stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for BIOLASE analysts is $ 21.38. Today 200 Day Moving Average is the resistance level (15.93 $).

Dec 1, 2023 · BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants PR Newswire Sep 18, 2023 8:30pm Dec 1, 2023 · The Soligenix, Inc stock price fell by -25.53% on the last day (Friday, 1st Dec 2023) from $0.98 to $0.730. During the last trading day the stock fluctuated 25.14% from a day low at $0.711 to a day high of $0.89. The price has been going up and down for this period, and there has been a 80.56% gain for the last 2 weeks. BIOLASE, Inc. (NASDAQ:BIOL) Q4 2022 Earnings Call Transcript March 28, ... GAAP net loss per share for the year 2022 was $4.13 compared to $2.73 in 2021 as adjusted for the reverse stock split.Detailed statistics for BIOLASE, Inc. (BIOL) stock, including valuation metrics, financial numbers, share information and more. ... Analyst Forecast. The average ...Analyzing the anticipated performance of BIOLASE, the ceiling value that the stock is expected to reach in 2025 stands at a promising $2.6.Indicating a bullish trend, an upside potential of 57.68% signals profitable prospects, with an average monthly return of 2.31%, beckoning investors to consider amplifying their portfolios. 21 sept 2023 ... Shares of Biolase saw signs of life in the stock market today. The ... Instead of waiting for its share price to climb, it has conducted a ...

hace 3 días ... The price of gold rose 1.1% to $2,080.80. —Kevin Costelloe. —. Nov. 30. HEALTHCARE. San Clemente-based ICU Medical Inc. (Nasdaq: ICUI) rose 4.8% ...Gen Restaurant Group Inc. (Nasdaq: GENK), also known as Gen Korean BBQ, fell 11% to $7.76 and a $250.8 million market cap. In third quarter earnings reported yesterday, the company reported revenue of $45.6 million, missing analyst estimates of $46.6 million. It also said comparable restaurant sales slipped 1.2% and operating …

Find real-time NKLA - Nikola Corp stock quotes, company profile, news and forecasts from CNN Business.WebBIOLASE stock price predictions for 2022 using artificial intelligence. How much will BIOLASE stock be worth in 2022? Target price in 2022.Analyst projections state that BIOL is forecast to be at a low of $4.00 and a high of $40.00. In order for the stock price to hit the forecast high, the stock would need to plunge -2295.21% from its current level, while the stock would need to crash -139.52% from its current level to reach the projected low. Biolase Inc (BIOL) estimates and ...BIOLASE is a company that develops and sells laser systems for dental procedures. The stock has a consensus rating of Buy and a price target of $513.50, with a forecasted upside of 30,132.6%. The company reported record revenue and earnings in the second quarter of 2023, and announced a public offering of preferred stock and warrants.According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.Real time Biolase (BIOL) stock price quote, stock graph, news & analysis.

Based on 2 Wall Street analysts offering 12 month price targets for Biolase in the last 3 months. The average price target is $4.00 with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 244.83% change from the last price of $1.16. Highest Price Target $4.00. Average Price Target $4.00.

US0909117022. BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to ...

Find real-time NKLA - Nikola Corp stock quotes, company profile, news and forecasts from CNN Business.WebThe Theriva Biologics, Inc. stock price gained 5.10% on the last trading day (Friday, 17th Nov 2023), rising from $0.390 to $0.410. During the last trading day the stock fluctuated 15.38% from a day low at $0.390 to a day high of $0.450. The price has been going up and down for this period, and there has been a -6.43% loss for the last 2 weeks.Stockholders Urged to Vote "FOR" the Reverse Stock Split. FOOTHILL RANCH, Calif., Oct. 27, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today issued a letter to stockholders concerning BIOLASE's upcoming special meeting of stockholders on November 19, 2021. BIOLASE's Board of Directors unanimously ...Biolase -20%. TELA Bio -18%. Adaptive Biotechnologies -14%. S&P 500 Health Care ... Goldman Sachs channels Taylor Swift for its 2024 stock market forecast Today, 4:48 PM 3 Comments.Web15.17R USD +13.93 +1123.12%. The 3 analysts offering 1 year price forecasts for Biolase, Inc. have a max estimate of 40.00 and a min estimate of 2.50. Nov 13, 2023 · BIOLASE, Inc. Provides Revenue Forecast for the Third Quarter Ending September 30, 2022 and Full Year of 2022 Aug 12 BIOLASE, Inc. to Report Q2, 2022 Results on Aug 11, 2022 Find the latest dividend history for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com.The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins. The company has insufficient levels of profitability. For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the …WebWall Street Stock Market & Finance report, prediction for the future: You'll find the Biolase share forecasts, stock quote and buy / sell signals below. According to present data Biolase's BIOL shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).

BIOLASE Inc (BIOL) stock has gained 26.32% while the S&P 500 is down -0.98% as of 10:40 AM on Monday, Dec 4. BIOL is up $0.30 from the previous closing …The SoFi stock price fell by -0.580% on the last day (Friday, 24th Nov 2023) from $6.90 to $6.86. During the last trading day the stock fluctuated 2.35% from a day low at $6.79 to a day high of $6.95. The price has risen in 6 of the last 10 days and is up by 0.15% over the past 2 weeks. Volume fell on the last day along with the stock, which is ...WebOct 27, 2021 · Stockholders Urged to Vote "FOR" the Reverse Stock Split. FOOTHILL RANCH, Calif., Oct. 27, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today issued a letter to stockholders concerning BIOLASE's upcoming special meeting of stockholders on November 19, 2021. BIOLASE's Board of Directors unanimously ... BIOLASE, Inc. Provides Revenue Forecast for the Third Quarter Ending September 30, 2022 and Full Year of 2022 ... Listing Qualifications Staff of Nasdaq Determines to Delist BIOLASE's Common Stock from the Nasdaq Capital Market and to Suspend Trading of the Common Stock at the Opening of Business on June 20 2023.Instagram:https://instagram. vanguard real estategame company stocknyse clshould i buy sofi stock Company SEC-Filings. Unfortunately, cash burn remains a major issue. In Q2, Biolase recorded negative free cash flow of $6.9 million and ended the quarter with $19.5 million in cash and cash ...WebOct 26, 2023 · Analyzing the anticipated performance of BIOLASE, the ceiling value that the stock is expected to reach in 2024 stands at a promising $2.56.Indicating a bullish trend, an upside potential of 49.75% signals profitable prospects, with an average monthly return of 3.55%, beckoning investors to consider amplifying their portfolios. oanda commission ratesbest broker for metatrader Biolase shares are trading lower after the company announced the pricing of a $4.5 million underwritten public offering. benzinga.com - May 24 at 10:11 AM. BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants.Web meaning of beta Biolase story: Dental Lasers Market Size,Growth And Forecast AMD Lasers,Biolase,Inc,Fotona DD,CAO Group,Dentsply Sirona,Yoshida Dental,Convergent Dental,Zolar Technology Business Merseyside Business …If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.BIOLASE is a company that develops and sells laser systems for dental procedures. The stock has a consensus rating of Buy and a price target of $513.50, with a forecasted upside of 30,132.6%. The company reported record revenue and earnings in the second quarter of 2023, and announced a public offering of preferred stock and warrants.